Below are the most recent publications written about "Endometrial Neoplasms" by people in Profiles.
-
Makker V, Aghajanian C, Cohn AL, Romeo M, Bratos R, Brose MS, Messing M, Dutta L, Dutcus CE, Huang J, Schmidt EV, Orlowski R, Taylor MH. A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. J Clin Oncol. 2023 Feb 10; 41(5):974-979.
-
Harkenrider MM, Abu-Rustum N, Albuquerque K, Bradfield L, Bradley K, Dolinar E, Doll CM, Elshaikh M, Frick MA, Gehrig PA, Han K, Hathout L, Jones E, Klopp A, Mourtada F, Suneja G, Wright AA, Yashar C, Erickson BA. Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline. Pract Radiat Oncol. 2023 Jan-Feb; 13(1):41-65.
-
Merfeld EC, Kuczmarska-Haas A, Burr AR, Witt JS, Francis DM, Ntambi JN, Desai VK, Huang JY, Miller JR, Lawless MJ, Wallace CR, Anderson BM, Bradley KA. Targeting the GTV in medically inoperable endometrial cancer using brachytherapy. Brachytherapy. 2022 Nov-Dec; 21(6):792-798.
-
Curcio E, Miller B, Giglio A, Akoluk A, Erler B, Bosscher J, Borowsky M, Hicks V, ElSahwi K. Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer. South Med J. 2021 11; 114(11):680-685.
-
Dondi G, Coluccelli S, De Leo A, Ferrari S, Gruppioni E, Bovicelli A, Godino L, Coada CA, Morganti AG, Giordano A, Santini D, Ceccarelli C, Turchetti D, De Iaco P, Perrone AM. An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach. Int J Mol Sci. 2020 Sep 29; 21(19).
-
Emiloju O, Candelario N, Dourado C. Metastatic clear cell endometrial carcinoma: an unusual cause of a common clinical presentation. BMJ Case Rep. 2020 Jun 11; 13(6).
-
Makker V, Taylor MH, Aghajanian C, Oaknin A, Mier J, Cohn AL, Romeo M, Bratos R, Brose MS, DiSimone C, Messing M, Stepan DE, Dutcus CE, Wu J, Schmidt EV, Orlowski R, Sachdev P, Shumaker R, Casado Herraez A. Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer. J Clin Oncol. 2020 09 10; 38(26):2981-2992.
-
Lin AE, Alali A, Starr LJ, Shah N, Beavis A, Pereira EM, Lindsay ME, Klugman S. Gain-of-function pathogenic variants in SMAD4 are associated with neoplasia in Myhre syndrome. Am J Med Genet A. 2020 02; 182(2):328-337.
-
Makker V, Rasco D, Vogelzang NJ, Brose MS, Cohn AL, Mier J, Di Simone C, Hyman DM, Stepan DE, Dutcus CE, Schmidt EV, Guo M, Sachdev P, Shumaker R, Aghajanian C, Taylor M. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2019 05; 20(5):711-718.
-
Goldberg A, Chan J. Microcystic, Elongated, and Fragmented Pattern Invasion in Ovarian Endometrioid Carcinoma. Int J Gynecol Pathol. 2018 09; 37(5):505.